Prospective, randomized study of one, two, or three trabecular bypass stents in open-angle glaucoma subjects on topical hypotensive medication

Documenti analoghi

• Long-term titrated IOP control with one, two, or three trabecular micro-bypass stents in open-angle glaucoma subjects on topical hypotensive medication: 42-month outcomes
  di: Katz, L Jay, et al.
  Pubblicazione: (2018)
• Implantation of two second‐generation trabecular micro‐bypass stents and topical travoprost in open‐angle glaucoma not controlled on two preoperative medications: 18‐month follow‐up
  di: Berdahl, John, et al.
  Pubblicazione: (2017)
• Efficacy of two trabecular micro-bypass stents combined with topical travoprost in open-angle glaucoma not controlled on two preoperative medications: 3-year follow-up
  di: Chang, David F, et al.
  Pubblicazione: (2017)
• Outcomes Following Implantation of Two Second-Generation Trabecular Micro-Bypass Stents in Patients with Open-Angle Glaucoma on One Medication: 18-Month Follow-Up
  di: Lindstrom, Richard, et al.
  Pubblicazione: (2016)
• Prospective unmasked randomized evaluation of the iStent inject(®) versus two ocular hypotensive agents in patients with primary open-angle glaucoma
  di: Fea, Antonio M, et al.
  Pubblicazione: (2014)